⌘K

Login Start Free

Home/Filings/4/0001437749-25-006735

4//SEC Filing

Cittadine Andrew 4

Accession 0001437749-25-006735

CIK 0001645469other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 9:09 PM ET

Size

11.4 KB

Accession

0001437749-25-006735

Insider Transaction Report

Form 4

Period: 2025-03-04

Monopar TherapeuticsMNPR

Cittadine Andrew

Chief Operating Officer

Transactions

Award
Restricted Stock Units
2025-03-04+40,581→ 51,655 total
Exercise: $0.00→ Common Stock (40,581 underlying)
Award
Stock Options
2025-03-04+43,445→ 43,445 total
Exercise: $31.70Exp: 2035-03-04→ Common Stock (43,445 underlying)

Footnotes (2)

[F1]Options Vests 6/48ths on June 30, 2025, and 1/48th per month thereafter.
[F2]RSUs vest 6/48ths on June 30, 2025, and 3/48ths per quarter thereafter.

Documents

2 files

Issuer

Monopar Therapeutics

CIK 0001645469

Entity typeother

Related Parties

1

filerCIK 0001863624

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 9:09 PM ET
Size: 11.4 KB

View on SEC.gov